School of Medicine
Showing 31-38 of 38 Results
-
Ashley Rene Styczynski
Postdoctoral Medical Fellow, Infectious Diseases
Fellow in MedicineBioAshley Styczynski, MD, MPH, is an infectious disease fellow in the Division of Infectious Diseases & Geographic Medicine with research interests in epidemiology, global health, emerging infections, and antimicrobial resistance. She holds an MPH from Johns Hopkins Bloomberg School of Public Health and an MD from University of Illinois at Chicago. Prior to coming to Stanford for her infectious disease fellowship, she spent two years as an Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention. During her time as an EIS officer, Ashley conducted outbreak investigations on Zika virus, vaccinia virus, and rabies. She is currently conducting research on antimicrobial resistance, transmission of COVID-19, and interventions to reduce nosocomial infections within low-resource healthcare facilities.
-
Jonas Dominique J Van Belleghem
Postdoctoral Research Fellow, Infectious Diseases
Current Research and Scholarly InterestsPhage Biology/Immunology.
-
Renu Verma
Postdoctoral Research Fellow, Infectious Diseases
BioOne of the key challenges in infectious diseases control is unavailability of rapid and low-cost diagnostics with high specificities and sensitivities. I am a Molecular-microbiologist currently working with Dr. Jason Andrews at the Division of Infectious Diseases. My research primarily focuses on applying novel strategies to detect Mycobacterium tuberculosis and SARS-CoV-2 in various sample types and environments for treatment and control of TB and COVID-19.
Key Research:
i)Development and validation of molecular viability assays for detection and quantification of novel SARS-CoV-2 virus in COVID-19 patients
ii)Development and validation of a novel aerosol capture tool for the detection of SARS-CoV-2 in exhaled breath from COVID-19 patients with mild and severe symptoms
iii)Development of a rapid pharmacogenomic assay to detect NAT2 polymorphisms and predict INH acetylation to guide dosing for tuberculosis treatment
iv)Detection of M. tuberculosis in the environment as a novel tool for identifying high-risk locations for tuberculosis transmission
v)Analyzing host serum biomarkers in latent and active Tuberculosis using ELISA assays in patients as a measure of disease severity.
